Pfm Health Sciences, LP Myriad Genetics Inc Transaction History

Pfm Health Sciences, LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$18.21 - $27.88 $7.92 Million - $12.1 Million	-435,112 Reduced 36.96%	742,138 $14.2 Million
Q2 2022 Aug 15, 2022	SELL	$16.45 - $25.88 $11.6 Million - $18.2 Million	-705,107 Reduced 37.46%	1,177,250 $21.4 Million
Q1 2022 May 16, 2022	SELL	$22.67 - $28.01 $3.25 Million - $4.01 Million	-143,324 Reduced 7.08%	1,882,357 $47.4 Million
Q4 2021 Feb 14, 2022	SELL	$24.13 - $32.63 $20.4 Million - $27.6 Million	-847,237 Reduced 29.49%	2,025,681 $55.9 Million
Q3 2021 Nov 15, 2021	SELL	$29.97 - $36.66 $6.48 Million - $7.93 Million	-216,234 Reduced 7.0%	2,872,918 $92.8 Million
Q2 2021 Aug 16, 2021	BUY	$25.39 - $32.61 $9.41 Million - $12.1 Million	370,529 Added 13.63%	3,089,152 $94.5 Million
Q1 2021 May 17, 2021	BUY	$19.92 - $31.6 $54.2 Million - $85.9 Million	2,718,623 New	2,718,623 $82.8 Million

253

90.5M

100K

34K

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.11B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

Get notified when there are updates to the investment portfolio of Pfm Health Sciences, LP, based on Form 13F filings with the SEC.

Stay updated on Pfm Health Sciences, LP with notifications on news.